
Browsing restrictions can be lifted for a fee.
Medimaging Integrated Solution Inc. provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope, including optical coherence tomography, control unit scopes, software, and accessories; computing-based AI screening in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions, a micro camera module for visualization performance and provides patient-oriented care; and micro camera modules. Medimaging Integrated Solution Inc. was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
6796
晉弘
-0.48%
(-0.00)
The most recent financial report for 晉弘 (6796) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6796's short-term business performance and financial health. For the latest updates on 6796's earnings releases, visit this page regularly.
According to historical valuation range analysis, 晉弘 (6796)'s current price-to-earnings (P/E) ratio is 153.47, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 晉弘 (6796) reported an Operating Profit of -9.63M with an Operating Margin of -6.3% this period, representing a growth of 53.53% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 晉弘 (6796) announced revenue of 152.79M, with a Year-Over-Year growth rate of 46.72%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 晉弘 (6796) held Total Cash and Cash Equivalents of 356.5M, accounting for 0.26 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 晉弘 (6796) did not achieve the “three margins increasing” benchmark, with a gross margin of 39.02%%, operating margin of -6.3%%, and net margin of 1.41%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6796's profit trajectory and future growth potential.
According to the past four quarterly reports, 晉弘 (6796)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.06. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
晉弘 (6796)'s Free Cash Flow (FCF) for the period is 200.65M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 1,221.09% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.